NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Monday that it has closed its $345 million offering of 1.25 percent convertible senior notes.

The offering includes $300 million of notes that were sold to qualified institutional investors and $45 million of notes that were issued pursuant to the exercise of an overallotment option by the notes' initial purchasers, Morgan Stanley and Jefferies. The notes are due in 2021.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.